gene

CREBBP

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about CREBBP: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

490Connections

0Hypotheses

0Analyses

50Outgoing

50Incoming

0Experiments

0Debates

Summary

CREBBP is a gene implicated in neurodegeneration research. Key relationships include: associated with, therapeutic target, regulates. Associated with Als, Amyotrophic Lateral Sclerosis, Cancer. Connected to 321 entities in the SciDEX knowledge graph.

View on Wiki →

No AI portrait yet

🧬 Gene Info

Gene Symbol	CREBBP
Full Name	CREB Binding Protein
Chromosome	16p13.3
Protein Type	Transcription Factor
Function	is a transcriptional coactivator that acetylates histones and transcription factors
Primary Expression	most neuronal subtypes including pyramidal cells, interneurons - Glia: Present in astrocytes and [microglia](/entities/mic
Molecular Weight	265 kDa
Pathways	NF-κB
UniProt ID	Q92793 (CREBBP)
NCBI Gene ID	1387
Ensembl ID	ENSG00000105383
OMIM	600140
GeneCards	CREBBP
Human Protein Atlas	CREBBP
Associated Diseases	ALS, Cancer, Parkinson, Tumor
Known Drugs/Compounds	rapamycin
Interactions	ACAT1, AMPK, AND, APOPTOSIS, ATG, BCL2
KG Connections	489 knowledge graph edges
Databases	GeneCards HPA STRING

🔮 Predicted Structure: CREBBP — AlphaFold Q92793 Click to expand

AI-predicted structure from AlphaFold | Powered by Mol*

Wiki Pages (2)

Knowledge base pages for this entity

Canonical Page

CREBBP Gene

gene · 680 words

→

CREBBP Protein

protein · 774 words

→

Pathway Diagram

graph TD
    CREBBP["CREBBP"] -->|"Regulates"| histone_H2B_acetylation["histone H2B acetylation"]
    CREBBP["CREBBP"] -->|"Associated With"| Tumor["Tumor"]
    CREBBP["CREBBP"] -->|"Associated With"| Parkinson["Parkinson"]
    CREBBP["CREBBP"] -->|"Therapeutic Target"| Cancer["Cancer"]
    CREBBP["CREBBP"] -->|"Therapeutic Target"| Ms["Ms"]
    CREBBP["CREBBP"] -->|"Therapeutic Target"| Glioblastoma["Glioblastoma"]
    CREBBP["CREBBP"] -->|"Therapeutic Target"| Fibrosis["Fibrosis"]
    CREBBP["CREBBP"] -->|"Therapeutic Target"| Hepatitis["Hepatitis"]
    OPTN["OPTN"] -->|"Associated With"| CREBBP["CREBBP"]
    ULK1["ULK1"] -->|"Associated With"| CREBBP["CREBBP"]
    CALCOCO2["CALCOCO2"] -->|"Associated With"| CREBBP["CREBBP"]
    HSPA8["HSPA8"] -->|"Associated With"| CREBBP["CREBBP"]
    STX17["STX17"] -->|"Associated With"| CREBBP["CREBBP"]
    style CREBBP fill:#8d4900,color:#e0e0e0
    style histone_H2B_acetylation fill:#1b5e20,color:#e0e0e0
    style Tumor fill:#b71c1c,color:#e0e0e0
    style Parkinson fill:#b71c1c,color:#e0e0e0
    style Cancer fill:#b71c1c,color:#e0e0e0
    style Ms fill:#b71c1c,color:#e0e0e0
    style Glioblastoma fill:#b71c1c,color:#e0e0e0
    style Fibrosis fill:#b71c1c,color:#e0e0e0
    style Hepatitis fill:#b71c1c,color:#e0e0e0
    style OPTN fill:#8d4900,color:#e0e0e0
    style ULK1 fill:#8d4900,color:#e0e0e0
    style CALCOCO2 fill:#8d4900,color:#e0e0e0
    style HSPA8 fill:#8d4900,color:#e0e0e0
    style STX17 fill:#8d4900,color:#e0e0e0

Outgoing (291)

Target	Relation	Type	Str
Reactive Oxygen Species	regulates	process	0.85
acetylation	promotes	process	0.85
Parkinson's Disease	regulates	disease	0.80
Cancer	therapeutic_target	disease	0.75
histone H2B acetylation	regulates	process	0.70
Parkinson	therapeutic_target	disease	0.65
Lung Cancer	therapeutic_target	disease	0.65
Fibrosis	therapeutic_target	disease	0.65
Hepatitis	therapeutic_target	disease	0.65
Carcinoma	therapeutic_target	disease	0.65
Als	therapeutic_target	disease	0.65
Inflammation	therapeutic_target	disease	0.65
Tumor	associated_with	disease	0.65
Parkinson	associated_with	disease	0.65
Colorectal Cancer	therapeutic_target	disease	0.65
Liver Cancer	therapeutic_target	disease	0.65
ALS	regulates	disease	0.65
Pulmonary Fibrosis	therapeutic_target	disease	0.65
Ms	therapeutic_target	disease	0.65
Lymphoma	interacts_with	disease	0.65
Carcinoma	interacts_with	disease	0.65
Infection	therapeutic_target	disease	0.65
Leukemia	inhibits	disease	0.65
Hepatocellular Carcinoma	therapeutic_target	disease	0.65
Prostate Cancer	therapeutic_target	disease	0.65
Cancer	interacts_with	disease	0.65
Tumor	interacts_with	disease	0.65
Gastric Cancer	therapeutic_target	disease	0.65
Cancer	associated_with	disease	0.65
Ms	inhibits	disease	0.65
Migraine	inhibits	disease	0.65
Pancreatic Cancer	therapeutic_target	disease	0.65
Glioblastoma	therapeutic_target	disease	0.65
Tumor	therapeutic_target	disease	0.65
Parkinson	regulates	disease	0.65
Cancer	inhibits	disease	0.65
Als	regulates	disease	0.65
Ms	regulates	disease	0.65
Amyotrophic Lateral Sclerosis	regulates	disease	0.65
Schizophrenia	activates	disease	0.65
Ms	contributes_to	disease	0.65
Cancer	expressed_in	disease	0.65
Ms	expressed_in	disease	0.65
Als	expressed_in	disease	0.65
Cancer	regulates	disease	0.65
AND	regulates	gene	0.60
KMT2D	interacts_with	gene	0.60
BCL2	interacts_with	gene	0.60
BCL2	therapeutic_target	gene	0.60
MYC	interacts_with	gene	0.60

Incoming (199)

Source	Relation	Type	Str
BECN1	regulates	gene	0.65
KAT2B	associated_with	gene	0.60
KAT5	associated_with	gene	0.60
WIPI2	associated_with	gene	0.60
BECN1	associated_with	gene	0.60
HDAC6	associated_with	gene	0.60
SOD2	therapeutic_target	gene	0.60
PPARGC1A	therapeutic_target	gene	0.60
SIRT3	therapeutic_target	gene	0.60
PRKAA1	therapeutic_target	gene	0.60
PIK3C3	associated_with	gene	0.60
TFEB	associated_with	gene	0.60
EP300	associated_with	gene	0.60
MTOR	associated_with	gene	0.60
NDP52	associated_with	gene	0.60
P62	associated_with	gene	0.60
PIK3CA	regulates	gene	0.60
CD44	regulates	gene	0.60
SRC	regulates	gene	0.60
EEF2	regulates	gene	0.60
SOD1	regulates	gene	0.60
FZD9	regulates	gene	0.60
FZD2	regulates	gene	0.60
GRB2	regulates	gene	0.60
EIF2AK2	regulates	gene	0.60
LRP1	interacts_with	gene	0.60
NR3C1	interacts_with	gene	0.60
GATA1	interacts_with	gene	0.60
MYC	interacts_with	gene	0.60
EP300	interacts_with	gene	0.60
MET	expressed_in	gene	0.60
RPL29	inhibits	gene	0.60
RPL36	inhibits	gene	0.60
MYC	inhibits	gene	0.60
EP300	inhibits	gene	0.60
SOD2	regulates	gene	0.60
PPARGC1A	regulates	gene	0.60
SIRT3	regulates	gene	0.60
FOXO1	regulates	gene	0.60
CREB	activates	gene	0.60
CBP	regulates	gene	0.60
CDH5	regulates	gene	0.60
GENES	therapeutic_target	gene	0.60
PARKINSON	therapeutic_target	gene	0.60
AND	therapeutic_target	gene	0.60
ACAT1	activates	gene	0.60
ATG	activates	gene	0.60
RB1	associated_with	gene	0.60
CDC42	interacts_with	gene	0.60
COL4A1	interacts_with	gene	0.60

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning CREBBP in their description or question text

No additional research found